ESC Premium Access

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

Congress Presentation

About the speaker

Professor Gb John Mancini

University of British Columbia, Vancouver (Canada)
2 presentations
0 follower

4 more presentations in this session

The Platelet Aggregation with tiCagrelor Inhibition and FentanYl Randomized Trial

Speaker: Professor J. Mcevoy (Galway, IE)


Stroke after coronary revascularization: an individual patient data pooled analysis of 11 randomised trials comparing percutaneous coronary intervention with coronary artery bypass grafting

Speaker: Doctor S. Head (Rotterdam, NL)


The EROSION study (Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion): A 1-Year Follow Up Study

Speaker: Professor I. Jang (Boston, US)


A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: final results of the Elderly-ACS

Speaker: Professor S. De Servi (Sesto San Giovanni, IT)


Access the full session

Late-Breaking Science Posters PCI

Speakers: Professor G. Mancini, Professor J. Mcevoy, Doctor S. Head, Professor I. Jang, Professor S. De Servi

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb